We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+1.5%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$21.4B
AUM Growth
-$3.07B
Cap. Flow
-$3.45B
Cap. Flow %
-16.12%
Top 10 Hldgs %
34%
Holding
335
New
40
Increased
37
Reduced
44
Closed
34

Sector Composition

Rank Sector Weight
1 Healthcare 28.83%
2 Technology 13.3%
3 Industrials 11.55%
4 Communication Services 11.47%
5 Financials 11.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BEKE icon
176
KE Holdings
BEKE
$19.6B
$4.99M 0.02%
273,000
GSQD
177
DELISTED
G Squared Ascend I Inc.
GSQD
$4.93M 0.02%
500,000
TCVA
178
DELISTED
TCV Acquisition Corp. Class A Ordinary Shares
TCVA
$4.9M 0.02%
500,000
CLAA
179
DELISTED
Colonnade Acquisition Corp. II
CLAA
$4.89M 0.02%
500,000
RKTA
180
DELISTED
Rocket Internet Growth Opportunities Corp.
RKTA
$4.88M 0.02%
500,000
LCA
181
DELISTED
Landcadia Holdings IV, Inc. Class A Common Stock
LCA
$4.87M 0.02%
500,000
HERA
182
DELISTED
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
$4.87M 0.02%
500,000
TIOA
183
DELISTED
Tio Tech A Class A Ordinary Share
TIOA
$4.84M 0.02%
500,000
SCOB
184
DELISTED
ScION Tech Growth II Class A Ordinary Shares
SCOB
$4.39M 0.02%
450,000
VPCB
185
DELISTED
VPC Impact Acquisition Holdings II Class A ordinary shre
VPCB
$4.19M 0.02%
425,000
TECX
186
Tectonic Therapeutic
TECX
$736M
$4.13M 0.02%
61,667
IPVF
187
DELISTED
InterPrivate III Financial Partners Inc.
IPVF
$3.96M 0.02%
400,000
FRSG
188
DELISTED
First Reserve Sustainable Growth Corp. Class A Common Stock
FRSG
$3.96M 0.02%
400,000
GIIX
189
DELISTED
Gores Holdings VIII, Inc. Class A Common Stock
GIIX
$3.93M 0.02%
400,000
GETR
190
DELISTED
Getaround, Inc.
GETR
$3.91M 0.02%
400,000
CCVI
191
DELISTED
Churchill Capital Corp VI
CCVI
$3.91M 0.02%
400,000
NDAC
192
DELISTED
NightDragon Acquisition Corp. Class A Common stock
NDAC
$3.91M 0.02%
400,000
TNGX icon
193
Tango Therapeutics
TNGX
$4.03B
$3.88M 0.02%
300,000
TPGS
194
DELISTED
TPG Pace Solutions Corp.
TPGS
$3.52M 0.02%
350,000
ACHL
195
DELISTED
Achilles Therapeutics
ACHL
$3.51M 0.02%
450,000
-546,540
-55% -$3.6M
LGV
196
DELISTED
Longview Acquisition Corp. II
LGV
$3.01M 0.01%
304,698
LGAC
197
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
$2.92M 0.01%
300,000
EMBK
198
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$2.76M 0.01%
13,901
GTPA
199
DELISTED
Gores Technology Partners, Inc. Class A Common Stock
GTPA
$2.46M 0.01%
250,000
DGNU
200
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
$2.45M 0.01%
250,000

Similar funds

Thomas Steyer's Q3 2021 Portfolio in Review

As of Q3 2021, Thomas Steyer held 335 positions worth $21.4B, down 13% from $24.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Thomas Steyer withdrew a net $3.45B in Q3 2021, closing 34 positions and reducing 44 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $1.42B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 30% a quarter earlier, followed by Technology and Industrials.

Against the trend, Thomas Steyer opened a new position in Macquarie Infrastructure Holdings, LLC worth $177M.

  • Thomas Steyer's largest Q3 2021 buy was Macquarie Infrastructure Holdings, LLC: 4,361,050 shares worth $177M.
  • Thomas Steyer added most to Aramark in Q3 2021, an estimated $209M increase.
  • Thomas Steyer's biggest Q3 2021 reduction was Willis Towers Watson, cutting an estimated $468M.
  • Thomas Steyer fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $1.42B.
  • Thomas Steyer's ten largest holdings make up 34% of its $21.4B portfolio in Q3 2021.
  • Thomas Steyer opened 40 new positions and closed 34 in Q3 2021.
  • Thomas Steyer's portfolio value fell 13% quarter-over-quarter to $21.4B.

Based on Farallon Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.